Mylan names 2 to board

  • February 11, 2013

CANONSBURG (AP) — Mylan Inc. said Monday that it has added two new members to its board of directors, expanding it to 13 members.

The pharmaceutical company’s board appointed Melina Higgins, a former partner at Goldman, Sachs & Co., and Rajiv Malik, Mylan’s president, to the board.

Higgins joined Goldman Sachs in 1989 and retired in 2010 after serving as a partner and in various leadership roles.

Malik has held important leadership positions at Mylan since January 2007, when the company acquired a controlling stake in Matrix Laboratories Ltd., now Mylan Laboratories Ltd. Malik was the CEO of the active pharmaceutical ingredients supplier.

Mylan Executive Chairman Robert J. Coury said the appointments deliver on the company’s objective of strengthening Mylan at all levels.

Mylan markets the EpiPen, an epinephrine auto-injector for treating severe allergic reactions. Pfizer Inc. makes EpiPen, and Mylan markets it in the U.S. Mylan also makes generic and specialty prescription drugs.


blog comments powered by Disqus

Work begins on outdoor venue at The Meadows

Consumer confidence falls hard in November

Home prices jump in September by most in more than a year

U.S. economy grew at 2.1 percent rate in third quarter

Markets fade after an early gain, finish with small losses

Home sales slump in Oct. as higher prices weigh on buyers

Pfizer, Allergan $160B deal forms world’s largest drugmaker

North Franklin woman uses art to help nonprofits while dealing with cystic fibrosis

Small talk: Obstacles, prejudice being overcome by deaf business owners

U.S. home rental prices rise at slower pace in October